Basic Parlodel Information

• INN (International Nonproprietary Name): Bromocriptine
• Brand Names Available In Canada (English): Parlodel; Parlodel Sandoz; Bromocriptin-ratiopharm; Cycloset (marketed in the US for diabetes)
• ATC Code: G02CB01 (Bromocriptine) — Prolactin inhibitors (ergot derivatives)
• Forms & Dosages: Tablets 2.5 mg commonly; 5 mg tablets exist in some markets but are rare
• Manufacturers In Canada (English): Not specified; global suppliers include Novartis/Novartis Sandoz, Ratiopharm, Teva and Zentiva
• Registration Status In Canada (English): Not specified
• OTC / Rx Classification: Rx only — prescription required in nearly all markets

Availability & Price Landscape

Major National Pharmacy Chains

Canadians often ask where to find parlodel or bromocriptine tablets near them.

Major national chains such as Shoppers Drug Mart and Rexall are common first stops for prescription bromocriptine 2.5 mg blister packs.

Regional players like London Drugs (Western Canada) and Jean Coutu (Quebec) also handle prescriptions and may stock generics rather than the originator Parlodel.

Stock at a particular store often depends on distributor contracts and which generic manufacturer the pharmacy buys from.

Online Pharmacy Trends In Canada

Online Canadian pharmacies list bromocriptine tablets but require a valid prescription upload or pharmacist verification before dispensing.

Some provinces restrict out-of-province dispensing and require adherence to provincial drug plan rules when claiming reimbursement.

Price comparisons between in-store and online sellers can be striking once provincial mark-ups and dispensing fees are added.

Price Ranges By Package Size

Typical retail packaging is blister packs of 2.5 mg tablets; 30- or 60-tablet packs are common forms for chronic therapy.

Retail price differences vary by province because dispensing fees and mark-ups differ between provincial formularies.

Many Canadians compare US online prices or consider Cycloset (a US bromocriptine formulation for diabetes) but differences in DINs and regulatory approvals complicate cross-border purchases.

Canadian Patient Insights & Satisfaction Levels

Forum And Review Platforms

People searching for real-world feedback often check Reddit Canada, HealthBoards and condition-specific forums.

Threads typically discuss starting strategies, side effects and whether a pharmacy stocked Parlodel or a generic bromocriptine product.

Reported Benefits And Challenges From Canadian Patients

Patients report clinical benefit for hyperprolactinemia and occasional use for Parkinson’s symptoms, with prolactin levels dropping after dose titration.

Common early problems are dose-related nausea, lightheadedness and fatigue, especially during the first days of therapy.

Satisfaction is higher when clinicians titrate slowly and provide antiemetic advice or bedtime dosing recommendations.

Challenges noted by Canadians include prescription access delays, regional stock-outs and variable pharmacist familiarity with older ergot derivatives versus cabergoline.

Quebec forums often raise questions about brand differences (Parlodel versus generics) and RAMQ reimbursement rules.

Product Overview & Brand Variants

INN And Brand Names Used In Canada

International Nonproprietary Name is bromocriptine.

Worldwide brand names include Parlodel, with generics such as Parlodel Sandoz, Bromocriptin-ratiopharm and other manufacturer labels.

In practice, Canadian pharmacies more commonly dispense generics with the same active INN than the originator Parlodel.

Legal Classification Under Health Canada

Bromocriptine is classified as an Rx-only medicine in nearly all markets, including Canada where prescriptions are required for dispensing.

Health Canada issues Drug Identification Numbers (DINs) for approved products and pharmacies must verify the DIN and prescription before dispensing.

Note: Cycloset is a bromocriptine formulation marketed for diabetes in the US and may have different labelling and indications compared with Canadian products.

Indications In Local Canadian Medical Practice

Approved Uses (Health Canada DIN Context)

Health Canada–labelled products generally align with international approvals for hyperprolactinemia, adjunctive Parkinson’s therapy and acromegaly.

Endocrinologists and neurologists in Canada usually reserve bromocriptine for cases where cabergoline is contraindicated or poorly tolerated.

Off-Label Patterns In Canadian Healthcare

Off-label uses follow international trends and appear in specialist settings, including research-driven interest in metabolic effects.

Routine diabetes management with bromocriptine (the Cycloset paradigm) is uncommon in Canada because it is primarily marketed in the US for glycaemic control.

When prescribing off-label, Canadian clinicians document their rationale and consider provincial drug-coverage rules for reimbursement.

How It Works In The Body

Layman’s Explanation

People often want a simple answer: how does parlodel help reduce milk production or movement problems?

Bromocriptine is a dopamine D2 agonist that tells the pituitary gland to make less prolactin, which stops inappropriate milk production and often restores normal menstrual cycles.

It also helps brain dopamine pathways and can improve some Parkinson’s-related symptoms by supporting dopaminergic tone.

Clinical Detail From Health Canada Resources

Mechanistically, bromocriptine is an ergot-derived D2 receptor agonist that suppresses prolactin and exerts partial effects on growth-hormone release.

Product monographs note dose-dependent effects and side effects such as orthostatic hypotension and nausea.

Close titration and monitoring of blood pressure and prolactin levels reduce tolerability problems in clinical practice.

Dosage & Administration

Standard Regimens Per Canadian Guidelines

Standard adult starting doses for hyperprolactinemia are 1.25–2.5 mg once or twice daily, titrated to effect.

Maintenance doses commonly reach up to 7.5 mg/day in divided doses, with reported maximums of 15 mg/day for some cases.

Acromegaly starts low and can be titrated higher; Parkinson’s regimens begin low and may reach higher specialist-managed ranges.

Adjustments By Patient Type

Start elderly patients at the low end and titrate slowly because of increased orthostatic hypotension and CNS sensitivity.

Use caution in hepatic or renal impairment and increase clinical monitoring as there are no formal adjustment tables in routine monographs.

Children receive treatment only under paediatric specialist guidance.

Practical tips: bedtime dosing and starting at very low doses reduce nausea during initiation.

Contraindications & Side Effects

Common (Health Canada-Approved List)

Absolute contraindications include uncontrolled hypertension, severe psychotic disorders and hypersensitivity to bromocriptine or ergot alkaloids.

Postpartum women with pre-eclampsia or eclampsia risk should not receive bromocriptine.

Common adverse effects are nausea, headache, dizziness, fatigue, orthostatic hypotension, constipation and nasal congestion.

Rare But Serious (With Canadian Pharmacovigilance Data)

Rare serious events reported internationally and monitored in Canada include cardiac valvulopathy, severe psychiatric reactions and pronounced hypotension.

Canada’s reporting of suspected adverse reactions is coordinated through the Canada Vigilance program and serious events should be reported promptly.

Practical pharmacy checklist: confirm cardiovascular and psychiatric history, advise on driving precautions and monitor blood pressure during titration.

Comparable Medicines In Canada

Alternatives Table (With DIN References)

Direct competitors include cabergoline (Dostinex/Cabaser) and quinagolide (Norprolac).

Cabergoline is generally preferred for hyperprolactinemia because of a longer half-life and usually better tolerability.

Pros And Cons List

• Cabergoline — Pros: less frequent dosing, often fewer side effects. Cons: cost and access may limit use in some patients.
• Bromocriptine — Pros: cost-effective generics are widely available; useful when cabergoline is not tolerated. Cons: requires more frequent dosing and can cause early nausea and hypotension.
• Quinagolide — Pros: non-ergot option in some markets. Cons: limited availability depending on provincial formularies.

Current Research & Trends

Major Canadian Or International Studies 2022–2025

Recent literature focuses on comparative tolerability of ergot derivatives versus newer agents and on bromocriptine’s metabolic effects.

Small trials and observational studies continue to evaluate glycaemic and metabolic outcomes following bromocriptine treatment, building on the Cycloset experience in the US.

Trend: most centres now favour cabergoline as first-line for hyperprolactinemia, leaving bromocriptine as an alternative when cost, supply or tolerance issues arise.

Common Patient Questions In Canada

Is parlodel covered by provincial drug plans?

Answer: Coverage depends on province and clinical indication; check Ontario Drug Benefit (ODB), BC PharmaCare and RAMQ for specific rules.

Can I switch from cabergoline to bromocriptine?

Answer: Yes, under clinician supervision with dose and monitoring adjustments.

Is a prescription needed?

Answer: Yes — bromocriptine is Rx-only in most markets and pharmacies verify prescriptions before dispensing.

Can I buy online from a US site?

Answer: Cross-border purchases carry risks because of different regulatory approvals and DINs, and customs or import restrictions may apply.

How to manage nausea?

Answer: Start low, take at bedtime, consider antiemetic therapy and take with food.

Regulatory Status

Health Canada Approval Process

Health Canada assesses safety, efficacy and quality before market authorisation and issues a Drug Identification Number (DIN) for each product variant.

DINs are used by pharmacies, prescribers and provincial plans to identify specific marketed products and to enable reimbursement claims.

Pharmacies should verify the DIN printed on packaging before dispensing a product labelled as Parlodel or a bromocriptine generic.

DIN Number Relevance

DINs support pharmacovigilance and product traceability, and are essential when reporting suspected adverse reactions to Canada Vigilance.

FDA-approved US formulations such as Cycloset may not have a Canadian DIN and are not interchangeable in Canadian reimbursement systems without regulatory pathways.

Visual Recommendations

Infographic Ideas For Canadian Context

Suggested visuals that help patients understand parlodel include a labelled blister-pack photo showing the 2.5 mg tablet, sized for lay readers.

Create a simple mechanism infographic: D2 agonist → pituitary prolactin drop → symptom relief, with a one-line caption for each step.

Other useful visuals are a dosing flowchart by indication, a provincial coverage map outlining ODB/PharmaCare/RAMQ nuances, and a quick comparison chart versus cabergoline.

Buying & Storage Advice

In-Store Vs. Online Canadian Purchase Tips

Buying in-store at Shoppers Drug Mart, Rexall, London Drugs or Jean Coutu gives immediate pharmacist counselling and easier DIN verification.

Online Canadian pharmacies offer convenience and price comparison but require secure prescription upload and may enforce provincial dispensing rules.

Verify online pharmacy licensing and look for provincial College registration or other accreditation before ordering.

In our online pharmacy, parlodel is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Proper Storage With Canadian Climate Considerations

Store bromocriptine tablets at room temperature away from excess moisture, heat and direct light.

Avoid bathroom storage where humidity spikes in humid summers or during winter showers can affect tablets.

Keep tablets in the original blister pack until use and carry a copy of the prescription when travelling.

Guidelines For Proper Use

Canadian Doctor/Pharmacist Advice Style

Start low and titrate slowly, taking initial doses at bedtime to reduce nausea.

Monitor blood pressure for orthostatic changes during dose escalation and check prolactin levels per endocrinology guidance.

Pharmacists should verify the DIN and counsel on side effects, driving precautions and when to seek medical attention for severe reactions.

Document the reason for any off-label use and liaise with provincial drug programs for pre-authorisation if reimbursement is being sought.

Delivery Across Canada (English)

Buying Checklist And Final Notes

Before purchasing, confirm the pharmacy holds a valid provincial licence and verifies the prescription and DIN on the packaging.

Ask the pharmacist about available generic manufacturers and whether the pack contains 2.5 mg tablets or a rarer 5 mg strength.

Keep follow-up appointments for prolactin checks and blood-pressure monitoring during titration.

Report any serious or unexpected adverse reactions to the dispensing pharmacy and to Canada Vigilance for pharmacovigilance tracking.

When switching therapies, have a clear plan with the prescriber for cross-titration and monitoring, especially when moving between cabergoline and bromocriptine.